Last reviewed · How we verify
P. vivax infected mosquito bites — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
P. vivax infected mosquito bites (P. vivax infected mosquito bites) — Socrates Herrera Valencia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| P. vivax infected mosquito bites TARGET | P. vivax infected mosquito bites | Socrates Herrera Valencia | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- P. vivax infected mosquito bites CI watch — RSS
- P. vivax infected mosquito bites CI watch — Atom
- P. vivax infected mosquito bites CI watch — JSON
- P. vivax infected mosquito bites alone — RSS
Cite this brief
Drug Landscape (2026). P. vivax infected mosquito bites — Competitive Intelligence Brief. https://druglandscape.com/ci/p-vivax-infected-mosquito-bites. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab